Status:

NOT_YET_RECRUITING

Intraoperative Parathyroid Hormone Monitoring to Guide Surgery in Renal hyperparathyroIdism

Lead Sponsor:

McMaster University

Conditions:

Secondary Hyperparathyroidism

Tertiary Hyperparathyroidism

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The goal of this pilot clinical is to determine the feasibility of a fully powered clinical trial to determine the effectiveness of intraoperative parathyroid hormone (IOPTH) criteria in guiding surge...

Detailed Description

Chronic kidney disease (CKD) is increasing in prevalence globally alongside rising rates of obesity and metabolic syndromes. The rates of secondary and tertiary hyperparathyroidism are expected to ris...

Eligibility Criteria

Inclusion

  • 18 years of age or older
  • Candidate for subtotal parathyroidectomy or total thyroidectomy with or without autotransplantation
  • Tertiary hyperparathyroidism and/or recurrent hyperparathyroidism OR secondary hyperparathyroidism diagnosed with any stage of chronic kidney disease

Exclusion

  • Undergoing parathyroidectomy for primary hyperparathyroidism
  • Pregnant or breastfeeding women
  • Undergoing revision parathyroidectomy
  • Undergoing minimally invasive or video-assisted parathyroidectomy
  • Unable to provide written consent to be participant in study
  • Unable to complete study follow-up visits

Key Trial Info

Start Date :

October 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2026

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06542315

Start Date

October 1 2024

End Date

June 1 2026

Last Update

August 7 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

St Joseph's Hospital

Hamilton, Ontario, Canada, L8N 3K7